Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF V600 /NRAS Q61 Wild-Type Melanoma (TraMel-WT). - Awada, Gil; Dirven, Iris; Schwarze, Julia Katharina; Tijtgat, Jens; Fasolino, Giuseppe; Kockx, Mark; Neyns, Bart (JCO Precision Oncology, 2024)